Wu P - Search Results

1

Synthesis, biological evaluation and quantitative structure-activities relationship of flavonoids as vasorelaxant agents.

Dong X, Liu T, Yan J, Wu P, Chen J, Hu Y. Dong X, et al. Among authors: wu p. Bioorg Med Chem. 2009 Jan 15;17(2):716-26. doi: 10.1016/j.bmc.2008.11.052. Epub 2008 Nov 24. Bioorg Med Chem. 2009. PMID: 19070497

2

Synthesis and biological evaluation of novel 2-arylamino-3-(arylsulfonyl)quinoxalines as PI3Kα inhibitors.

Wu P, Su Y, Liu X, Zhang L, Ye Y, Xu J, Weng S, Li Y, Liu T, Huang S, Yang B, He Q, Hu Y. Wu P, et al. Eur J Med Chem. 2011 Nov;46(11):5540-8. doi: 10.1016/j.ejmech.2011.09.015. Epub 2011 Sep 17. Eur J Med Chem. 2011. PMID: 21945250

3

Flavonoids as vasorelaxant agents: synthesis, biological evaluation and quantitative structure activities relationship (QSAR) studies.

Dong X, Wang Y, Liu T, Wu P, Gao J, Xu J, Yang B, Hu Y. Dong X, et al. Among authors: wu p. Molecules. 2011 Sep 28;16(10):8257-72. doi: 10.3390/molecules16108257. Molecules. 2011. PMID: 21959298 Free PMC article.

4

Searching for the Multi-Target-Directed Ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H₃R and BACE 1 inhibitory activities.

Huang W, Tang L, Shi Y, Huang S, Xu L, Sheng R, Wu P, Li J, Zhou N, Hu Y. Huang W, et al. Among authors: wu p. Bioorg Med Chem. 2011 Dec 1;19(23):7158-67. doi: 10.1016/j.bmc.2011.09.061. Epub 2011 Oct 5. Bioorg Med Chem. 2011. PMID: 22019465

5

Discovery of novel 2-piperidinol-3-(arylsulfonyl)quinoxalines as phosphoinositide 3-kinase α (PI3Kα) inhibitors.

Wu P, Su Y, Liu X, Yang B, He Q, Hu Y. Wu P, et al. Bioorg Med Chem. 2012 May 1;20(9):2837-44. doi: 10.1016/j.bmc.2012.03.026. Epub 2012 Mar 17. Bioorg Med Chem. 2012. PMID: 22480851

6

Design, synthesis and biological evaluation of novel imidazolone derivatives as dipeptidyl peptidase 4 inhibitors.

Liu Y, Jiang C, Wu H, Wu P, Si M, Hu Y, Liu T. Liu Y, et al. Among authors: wu h, wu p. Med Chem. 2013 Nov;9(7):938-46. doi: 10.2174/1573406411309070007. Med Chem. 2013. PMID: 23083118

7

Synthesis and biological evaluation of novel benzyl-substituted (S)-phenylalanine derivatives as potent dipeptidyl peptidase 4 inhibitors.

Liu Y, Si M, Tang L, Shangguan S, Wu H, Li J, Wu P, Ma X, Liu T, Hu Y. Liu Y, et al. Among authors: wu h, wu p. Bioorg Med Chem. 2013 Sep 15;21(18):5679-87. doi: 10.1016/j.bmc.2013.07.034. Epub 2013 Jul 25. Bioorg Med Chem. 2013. PMID: 23938053

8

PI3K inhibitors for cancer therapy: what has been achieved so far?

Wu P, Liu T, Hu Y. Wu P, et al. Curr Med Chem. 2009;16(8):916-30. doi: 10.2174/092986709787581905. Curr Med Chem. 2009. PMID: 19275602

9

Dual-target-directed 1,3-diphenylurea derivatives: BACE 1 inhibitor and metal chelator against Alzheimer's disease.

Huang W, Lv D, Yu H, Sheng R, Kim SC, Wu P, Luo K, Li J, Hu Y. Huang W, et al. Among authors: wu p. Bioorg Med Chem. 2010 Aug 1;18(15):5610-5. doi: 10.1016/j.bmc.2010.06.042. Epub 2010 Jun 17. Bioorg Med Chem. 2010. PMID: 20620068

10

QSAR models for isoindolinone-based p53-MDM2 interaction inhibitors using linear and non-linear statistical methods.

Dong X, Yan J, Lu D, Wu P, Gao J, Liu T, Yang B, Hu Y. Dong X, et al. Among authors: wu p. Chem Biol Drug Des. 2012 May;79(5):691-702. doi: 10.1111/j.1747-0285.2012.01322.x. Epub 2012 Feb 9. Chem Biol Drug Des. 2012. PMID: 22233482

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,090 results

Search Page

Filters